Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Personal Finance and Investing

Showing Original Post only (View all)

BWdem4life

(2,502 posts)
Fri Jun 7, 2024, 12:49 AM Jun 2024

I try not to do this too often, but... Here's a stock tip [View all]

Required disclaimer:

This is ONLY for those who enjoy managing their own portfolios and trying to outperform the market. There is no guarantee that any individual stock (or any fund, for that matter) will rise. Market timing can be risky and time-consuming, and the average investor should avoid any attempt at doing so.

The stock in question has been trading since 2001: HBIO (Harvard Bioscience, Inc.)

Company profile:

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

(Source: Fidelity.com)

Chart:



It’s currently trading within the bottom 5% of its historical price, adjusted for inflation. So far (since 2001) it has never stayed this low for more than 6 months (usually less).

I tried to put in an order for $2.99 tonight but there was an issue - For stocks trading under $3.00, you couldn’t purchase it with money that hadn’t yet cleared. Simple solution: I put in a limit order for $3.00

Anyway, that’s my tip of the moment.

In case the first warning didn’t stick: Past performance does not guarantee future performance, and I am not a financial advisor.

Good luck, fellow traders!

1 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
Latest Discussions»Culture Forums»Personal Finance and Investing»I try not to do this too ...»Reply #0